Display options
Cite
Patil SS, Patil SM, Campbell R, et al. Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient. Case Rep Med. 2020;2020:6186471doi: 10.1155/2020/6186471.
Patil, S. S., Patil, S. M., Campbell, R., Singh, M., & Plotkin, M. (2020). Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient. Case reports in medicine, 20206186471. https://doi.org/10.1155/2020/6186471
Patil, Shakuntala S, et al. "Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient." Case reports in medicine vol. 2020 (2020): 6186471. doi: https://doi.org/10.1155/2020/6186471
Patil SS, Patil SM, Campbell R, Singh M, Plotkin M. Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient. Case Rep Med. 2020 Nov 07;2020:6186471. doi: 10.1155/2020/6186471. eCollection 2020. PMID: 33224201; PMCID: PMC7669357.
Copy Download .nbib Format: NLM
Share it on

Case Rep Med. 2020 Nov 07;2020:6186471. doi: 10.1155/2020/6186471. eCollection 2020.

Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient.

Case reports in medicine

Shakuntala S Patil, Sachin M Patil, Ryan Campbell, Manisha Singh, Matthew Plotkin

Affiliations

  1. University of Missouri Hospital and Clinic, 1 Hospital Drive, Columbia, MO 65212, USA.

PMID: 33224201 PMCID: PMC7669357 DOI: 10.1155/2020/6186471

Abstract

Medication-induced cutaneous hyperpigmentation has variable clinical presentations and is dependent on the specific drug involved. Most commonly, an attentive patient observes such changes early in the course; when missed by the patient, such changes are usually noted by an observant clinician. Clinical diagnosis can be challenging if the patient is on multiple medications because other causes must be excluded. This condition occurs via multiple mechanisms. Frequently, the pigmentary change is reversible with discontinuation of the drug. Causative medications include nonsteroidal; anti-inflammatory agents, antimalarials, antibiotics, psychotropics, amiodarone, and chemotherapeutic agents. The; antimicrobials responsible for hyperpigmentation are antimalarials, tetracyclines, tigecycline, dapsone, rifampicin, and antiretrovirals such as zidovudine. Sunlight exposure can worsen the pigmentation seen with some of the above antimicrobials (e.g., dapsone). Here, we describe an older adult white woman presenting with acute cutaneous; hyperpigmentation of the bilateral lower extremities while on levofloxacin therapy. Hyperpigmentation resolved after cessation of the agent. Our case highlights this unique acute presentation after only a few days of oral levofloxacin.

Copyright © 2020 Shakuntala S. Patil et al.

Conflict of interest statement

The authors declare that they have no conflicts of interest.

References

  1. Arch Dermatol. 1995 Jul;131(7):856-7 - PubMed
  2. Dermatol Online J. 2018 Jul 15;24(7): - PubMed
  3. J Dtsch Dermatol Ges. 2017 Sep;15(9):949-951 - PubMed
  4. Arch Dermatol. 2007 Nov;143(11):1441-6 - PubMed
  5. Am J Clin Dermatol. 2001;2(4):253-62 - PubMed
  6. Actas Dermosifiliogr. 2019 Oct;110(8):700-701 - PubMed
  7. J Am Board Fam Med. 2019 Jul-Aug;32(4):628-638 - PubMed

Publication Types